Polpharma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Polpharma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0463
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary supplements, cosmetic products, medical devices and phyto-pharmaceuticals as well as active pharmaceutical ingredients (APIs). Polpharma has seven manufacturing plants in Russia, Poland and Kazakhstan. The company operates in Central and Eastern Europe, the Caucasus and Central Asia markets. Polpharma group includes Santo, Medana SA, Akrikhin Pharmaceuticals, Polfa Warszawa S.A. Polpharma is headquartered in Starogard Gdanski, Poland.

Polpharma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Polpharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Polpharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Polpharma SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Polpharma Enters into Agreement with Epirus Biopharma 10
Debt Offering 11
Khimfarm Plans Public Offering Of Senior Notes For US$66 Million 11
Asset Transactions 12
Pfizer Completes Acquisition Of Polocard From Polpharma For US$32 Million 12
Aflofarm Plans To Acquire Polocard From Polpharma 13
Acquisition 14
Polpharma to Acquire EPIRUS Netherlands from EPIRUS Biopharma 14
Polpharma Completes Acquisition Of 85.14% Stake In Polfa Warszawa For US$249 Million 16
Polpharma SA – Key Competitors 18
Polpharma SA – Key Employees 19
Polpharma SA – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Polpharma SA, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Polpharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Polpharma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Polpharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Polpharma Enters into Agreement with Epirus Biopharma 10
Khimfarm Plans Public Offering Of Senior Notes For US$66 Million 11
Pfizer Completes Acquisition Of Polocard From Polpharma For US$32 Million 12
Aflofarm Plans To Acquire Polocard From Polpharma 13
Polpharma to Acquire EPIRUS Netherlands from EPIRUS Biopharma 14
Polpharma Completes Acquisition Of 85.14% Stake In Polfa Warszawa For US$249 Million 16
Polpharma SA, Key Competitors 18
Polpharma SA, Key Employees 19
Polpharma SA, Other Locations 20
Polpharma SA, Subsidiaries 21

List of Figures
Polpharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Polpharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Polpharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Polpharma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Independent Order of Foresters:企業の戦略的SWOT分析
    The Independent Order of Foresters - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Sinclair Oil Corporation:企業の戦略・SWOT・財務情報
    Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hycrete Inc:企業の戦略的SWOT分析
    Hycrete Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Formosa Petrochemical Corp (6505):企業の財務・戦略的SWOT分析
    Formosa Petrochemical Corp (6505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Vivus Inc (VVUS):企業の財務・戦略的SWOT分析
    Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cummins Inc (CMI):電力:M&Aディール及び事業提携情報
    Summary Cummins Inc. (Cummins), formerly Cummins Engine Company, is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment dev …
  • Great-West Lifeco Inc.:企業の戦略・SWOT・財務情報
    Great-West Lifeco Inc. - Strategy, SWOT and Corporate Finance Report Summary Great-West Lifeco Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NII Holdings Inc (NIHD):企業の財務・戦略的SWOT分析
    Summary NII Holdings Inc (NII Holdings) is a mobile communication service provider that offers communication products and services. The company offers solutions such as 3G mobile broadband services, content downloads and messaging. It also provides digital cellular voice services, data services, and …
  • Huaneng Power International, Inc.:企業の戦略・SWOT・財務情報
    Huaneng Power International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Huaneng Power International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Pine Cliff Energy Ltd (PNE):企業の財務・戦略的SWOT分析
    Summary Pine Cliff Energy Ltd (Pine Cliff) is an oil and gas company that offers exploration, production, and development of natural gas, crude oil, and natural gas liquids. The company operates through its core areas such as Edson Assets, Central Assets, and Southern Assets. It acquired Hatton prop …
  • UniCredit S.p.A:戦略・SWOT・企業財務分析
    UniCredit S.p.A - Strategy, SWOT and Corporate Finance Report Summary UniCredit S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sodexo Inc:企業の戦略的SWOT分析
    Sodexo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Petrol dd Ljubljana (PETG):企業の財務・戦略的SWOT分析
    Petrol dd Ljubljana (PETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Abg Sundal Collier Holding Asa:企業の戦略・SWOT・財務分析
    Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report Summary Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • United Continental Holdings Inc:戦略・SWOT・企業財務分析
    United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Komatsu Ltd.:企業の戦略・SWOT・財務情報
    Komatsu Ltd. - Strategy, SWOT and Corporate Finance Report Summary Komatsu Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Dynasty Fine Wine Group Limited:企業の戦略・SWOT・財務分析
    Dynasty Fine Wine Group Limited - Strategy, SWOT and Corporate Finance Report Summary Dynasty Fine Wine Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • LumiraDx Ltd (LMDX):企業の財務・戦略的SWOT分析
    LumiraDx Ltd (LMDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Development Center for Biotechnology:製薬・医療:M&Aディール及び事業提携情報
    Summary Development Center for Biotechnology (DCB) is a non profit organization that offers support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and develop …
  • OMRON Corporation:企業の戦略・SWOT・財務情報
    OMRON Corporation - Strategy, SWOT and Corporate Finance Report Summary OMRON Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆